Optimization of a Tool for Predicting Postoperative Clinical Evolution After Lumbar Surgery (DeepSurgery)

February 9, 2023 updated by: Cortexx Medical Intelligence

Optimization of a Tool for Predicting Postoperative Clinical Evolution After Lumbar Surgery Multicenter Longitudinal Prospective Study on a National Cohort Clinical Evolution After Lumbar Surgery

The objective of the study is the establishment, optimization and prospective evaluation of a digital predictive platform capable of providing for each lumbar spine operated patient a clinical predictive status: Patient green (success) orange (treatment failure ), red patient (complication) in order to optimize his medical care up to 6 months.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75005
        • Clinique Geoffroy Saint-Hilaire
    • Nouvelle Aquitaine
      • Bruges, Nouvelle Aquitaine, France, 33520
        • Polyclinique Jean Villar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Major patient
  • Eligible for lumbar decompression surgery, instrumented or not
  • Social insured
  • Having given consent
  • Eligible for the acts described in Protocole

Exclusion Criteria:

  • Minor
  • Pregnant or breastfeeding woman
  • Safeguard measure or guardianship
  • Arthrodesis on more than 2 levels
  • Interventions linked to a traumatic or infectious context are excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SuMO Patient

92 data will be collected during the patient care episode. Among the 92 criteria, 63 are pre-operative, 29 are post-operative in order to provide an evolutionary prediction during the management of the patient.

Post-operative follow-up criteria making it possible to establish the scalability or non-scalability of the quality of life after the surgical procedure.

The results will be compared to the prediction proposed by the machine learning algorithm.

The current study is interventional insofar as the patient is collecting all of his socio-medical information. The analysis of the data provided by the patient makes it possible to establish a long-term prognosis for the patient but does not in itself constitute a parallel medical approach.

SUMO allows the surgeon to transmit post-operative advice developed by the surgeons themselves.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimization of a tool for predicting the postoperative clinical course after lumbar surgery
Time Frame: 14 months
Establishment and prospective evaluation of a predictive tool with the area under the receiver operating characteristic (AUROC) metric >= 80% Sensitivity >= 90% Specificity >= 60% in the capacity of providing for each back operated patient a clinical predictive status: green patient (success) orange (treatment failure), red patient (complication).
14 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collection of optimized data in the patient operative long terms care
Time Frame: 14 months

Implementation, optimization and evaluation of a digital tool for collecting patient data on the episode of care

Outcome (unit) - Result expected assessment time connection means preoperatively (second/connection) - 300s time 'use and navigation (second) - 1800s number of connections made by the patient preoperatively (number) - 5 number of connections / day before operation (number) - 1 number of use (number) - 15 number of drops / connection (Ratio%) - <20% number of lost view (no connection> 20 days) (Ratio%) - <10% evaluation of average using time post-operative (second/connections) - 300 Time of use and navigation (second) - 1800 number of connections made by the patient in post -operative (number) - 5 number of connections / day after operation (number)- 1 number of uses (number) - 15 number of withdrawals (Ratio%) - <20% number of lost to follow-up (no connection> 20 days) (Ratio%) - <10% number of documents analyzed / patient (number) - 10

14 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 15, 2021

Primary Completion (ACTUAL)

June 30, 2022

Study Completion (ACTUAL)

December 30, 2022

Study Registration Dates

First Submitted

November 16, 2021

First Submitted That Met QC Criteria

December 8, 2021

First Posted (ACTUAL)

December 21, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2023

Last Update Submitted That Met QC Criteria

February 9, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DeepSurgeryMH_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Study Data/Documents

  1. Individual Participant Data Set
    Information identifier: SUMO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on SuMO Patient

Subscribe